Similar articles

• Role of tissue factor pathway inhibitor in the regulation of tissue factor-dependent blood coagulation.

  Golino P, Ragni M, Cimmino G, Forte L. Golino P, et al. Cardiovasc Drug Rev. 2002 Winter;20(1):67-80. doi: 10.1111/j.1527-3466.2002.tb00083.x. Cardiovasc Drug Rev. 2002. PMID: 12070535 Review.
• TFPI-dependent activities of protein S.

  Peraramelli S, Rosing J, Hackeng TM. Peraramelli S, et al. Thromb Res. 2012 May;129 Suppl 2:S23-6. doi: 10.1016/j.thromres.2012.02.024. Epub 2012 Mar 15. Thromb Res. 2012. PMID: 22425215 Review.
• [Effect of erythropoietin on tissue factor and tissue factor pathway inhibitor in uremic hemodialysis patients].

  Bronowicz A, Perkowski H, Pawlak K. Bronowicz A, et al. Pol Arch Med Wewn. 2004 Jul;112(1):787-96. Pol Arch Med Wewn. 2004. PMID: 15526838 Clinical Trial. Polish.
• Platelet tissue factor pathway inhibitor modulates intravascular coagulation.

  Maroney SA, Mast AE. Maroney SA, et al. Thromb Res. 2012 May;129 Suppl 2(Suppl 2):S21-2. doi: 10.1016/j.thromres.2012.02.023. Epub 2012 Mar 17. Thromb Res. 2012. PMID: 22425319 Free PMC article. Review.
• Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli.

  Randolph MM, White GL, Kosanke SD, Bild G, Carr C, Galluppi G, Hinshaw LB, Taylor FB Jr. Randolph MM, et al. Thromb Haemost. 1998 May;79(5):1048-53. Thromb Haemost. 1998. PMID: 9609245